Alzheimer's Disease

Two new studies are building on a hypothesis that multiple sclerosis (MS) can be triggered by viral infections in a person’s teenage years. The research raises concerns the current COVID-19 pandemic could lead to a surge in MS cases in the future.

The interplay between high blood pressure and brain health is one scientists continue to shed new light on, with a new study finding even those with readings at the higher end of the normal recommended range can be at risk of premature brain aging.

Researchers on the hunt for a pre-approved medicine that can be repurposed to treat Alzheimer’s disease have found exposure to a common diuretic drug could significantly reduce a person’s risk of developing the disease.

Earlier detection of dementia could open up far more effective ways to treat and manage the condition. A new study has pinpointed "harbinger" molecules that could predict onset two to five years in advance, and may provide new targets for therapies.

A new study led by scientists from University College London proposes a key gene variant, known to heighten one’s risk for Alzheimer’s, stimulates the body’s inflammatory responses and can lead to greater susceptibility to severe COVID-19.

A drug originally designed to treat Alzheimer’s has been found to reduce obesity and improve heart function in mice. The drug was previously found to be ineffective treating dementia, but it's suggested it could be useful in stimulating fat metabolism.

A new study has explored how the blood-brain barrier might be shored up through the use of an existing anti-cancer drug, with the authors demonstrating some promising results around reversing cognitive decline in mice.

An impressive new study is presenting robust evidence showing the toxic proteins thought to be the cause of Alzheimer’s disease may be produced in the liver and travel through the blood before landing in the brain causing neuron damage.

A new study is suggesting a novel causal link between neurodegenerative diseases such as Alzheimer’s and infection with the herpesvirus. The preclinical research indicates a deficiency in a key protein allows the virus to trigger neuronal damage.

A new study has shone compelling new light on the way Alzheimer's proteins disrupts synaptic connections, demonstrating how these toxic agents take aim at the "Achilles' heel" of synapses, and better yet, how they might just be stopped.

A new study is reporting a link between a particular class of drugs used to treat type 2 diabetes and decreased Alzheimer's disease biomarkers. Alzheimer’s experts are calling for clinical trials to explore these treatments in people without diabetes.

A new study has expanded our knowledge of the relationship between brain cholesterol and Alzheimers, by observing how one influences the other in live mice and demonstrating how the process could be manipulated to slow the disease.